In this edition
- Menopause Down Under, Sydney | Saturday 6 April 2024
- IMS World Congress on Menopause in Melbourne 2024
- ASPOG 2024 Breaking the Boundaries, Bridging gapsÂ
Health Professionals - join AMS for Members-only contentÂ
- Vaginal erbium laser for the treatment of stress urinary incontinence
- Genitourinary symptoms and sexual function in women with primary ovarian insufficiency
- March 2024 Menopause e-Consult
- Non-Hormonal Pharmacological Interventions For VMS - IMS webinar online now
- Personalized oral combined MHT and long-term effects: How to choose according to the patient’s needs Webinar
- International Menopause Society (IMS) NewsletterÂ
- European Menopause and Andropause Society (EMAS) NewsletterÂ
In this edition
Menopause Down Under, Sydney | Saturday 6 April 2024
At Rydges World Square, Sydney on Saturday 6 April 2024, AMS will be hosting Menopause Down Under.
This whole day event will focus on midlife women's health issues down under
Join us for an up-to-date discussion on the fundamentals of menopause medicine, management of bleeding whilst on menopausal hormonal therapy, pelvic floor dysfunction and incontinence, and management of genitourinary syndrome of the menopause.
There will be a panel discussion on managing complex cases.
This is a great opportunity to hear from some of Australia's experts in the field of midlife women's health and to network with colleagues.
This face-to-face event will also be live-streamed for health professionals who cannot make it to Sydney.
Please note that online attendees will not be able to ask questions of the presenters.
Registration
| Â |
AMS members
|
General Admission
|
|
Face-to-Face
|
$49
|
$149
|
|
Online
|
$20
|
$59
|
Booking
Menopause Down Under
Program
See Program and information on Speakers online here
IMS World Congress on Menopause in Melbourne 2024
Registrations are now open for the IMS World Congress in Melbourne this October. AMS members have access to the same discounted IMS member rate for the IMS World Congress on Menopause in Melbourne, 19-22 October 2024.
Registration for Australian and New Zealand trainees is FREE until 23 September 2024.
We look forward to welcoming you to the IMS World Congress on Menopause.
AEPCOS Annual Meeting 7-9 November 2024, Queenstown New Zealand
HOLD THE DATE!  November 7-9, 2024
The meeting will be held in Queenstown, New Zealand at the Millenium Hotel from 7th to 9th November 2024.
The theme for the 22nd Annual Meeting will be Life-Long Sequelae in PCOS. The meeting will explore recent mechanistic and clinical advances related to cardiovascular, metabolic and psychological health in this chronic, lifelong condition, highlighting the latest research findings in PCOS-related basic and clinical research.
https://ae-society.org/
Health Professionals - join AMS for Members-only contentÂ
IMS Live 18 March 2024:Â Vaginal erbium laser for the treatment of stress urinary incontinence: optimization of therapeutical regimen for a sustained long-term effect
Stress urinary incontinence (SUI) is a common health problem that affects more or less 35% of women in the reproductive period. Gaspar et al. [1] conducted a prospective uncontrolled study in order to assess the long-term efficacy and safety of a non-ablative Er:YAG laser treatment of SUI in forty-three patients (n=43). All women underwent three sessions of IncontiLase® procedure, and the efficacy of the laser treatment was evaluated by 1-h pad test, 24-h pad test, 3-day voiding diary, and the use of ICIQ-UI SF questionnaire at multiple follow-ups. Patients were questioned regarding discomfort during the treatment and any adverse events occurring after the laser procedures...
IMS Live 25 March 2024:Â Genitourinary symptoms and sexual function in women with primary ovarian insufficiency
Recently, Blümel et al. [1] published data of a cross-sectional study performed in seven Latin American countries aiming to compare urogenital symptoms, including sexuality, of women with primary ovarian insufficiency (POI) to those without the condition. For this, 1,190 postmenopausal women (n=401 had POI; and n=789 did not) were surveyed with a general questionnaire, the Menopause Rating Scale (MRS) and the six-item Female Sexual Function Index (FSFI-6). The association of POI with more urogenital symptoms and lower sexual function was evaluated with logistic regression analysis...
March 2024 Menopause e-Consult
Question: A 56-year-old woman was diagnosed with left breast ductal carcinoma in situ at age 45.Â
Case: A 52-year-old woman presents to her menopause healthcare clinician having had 3 months of vaginal bleeding.
Non-Hormonal Pharmacological Interventions For VMS - IMS webinar online now
Personalized oral combined MHT and long-term effects: How to choose according to the patient’s needs Webinar
International Menopause Society (IMS) Newsletter See a copy of the IMS March newsletter Â
European Menopause and Andropause Society (EMAS) Newsletter AMS is an affiliate of EMAS. See latest copy.
